Company profile
Spectral Medical Inc
OTC: EDTXF · Healthcare · Medical - Specialties
Canadian filerHQ Toronto, ONReports USD
#816 of 1,418 Healthcare companies by revenue48th-percentile growth
EA Score
31DFH 16DQ —GM 60SS 61
v0.1 · 45/100 weight · provisional
↑ growth stability, market scale · ↓ return on assets, balance-sheet leverage
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
+2.7%
Net income (FY)
-$34.1M
Employees
29
as of 2026-08-13
Market cap
$287.1M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.7M2.4M CAD2025
Net income-$34.1M-47.7M CAD2025
Operating income-$8.4M-11.7M CAD2025
Total assets$4.4M6.1M CAD2025
Liabilities$55.3M75.8M CAD2025
Equity-$50.8M-69.7M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Spectral Medical Inc’s revenue?
Spectral Medical Inc booked $1.7M in FY2025 revenue, growing 4.6% year over year — about the middle of the pack among Healthcare companies we track, at a -1953.0% net margin.
Peers · Healthcare
Bionik Laboratories Corp.——Nutranomics, Inc.——CanaFarma Hemp Products Corp.——VolitionRX Ltd40DClearside Biomedical, Inc.——Rani Therapeutics Holdings, Inc.41DKey facts
CEOChris Seto
SectorHealthcare
IndustryMedical - Specialties
HeadquartersToronto, ON
ExchangeOTC: EDTXF
Employees29
IPO date2009-12-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.